Literature DB >> 11369512

Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2.

P Mitra1, A De, M F Ethier, K Mimori, K Kodys, K Shibuta, M Mori, J M Madison, C Miller-Graziano, G F Barnard.   

Abstract

Expression of the chemokine stromal cell-derived factor-1alpha (SDF-1alpha) is absent from many carcinomas, including hepatomas. We note an early signalling defect in the hepatocellular carcinoma (HCC) cell line HepG2 that expresses the CXCR4 receptor and binds biotin-labelled SDF, but fails to stimulate downstream signalling events after engagement with SDF. In HepG2, the SDF/CXCR4 interaction did not result in calcium influx, phosphorylation and internalization of CXCR4, nor in a rapid phosphorylation of p44/42 MAP kinase. There were no CXCR4 mutations in the second chemokine binding loop or C terminal phosphorylation and internalization domains. The downstream signalling machinery in HepG2 appears to be intact since transfection of wild-type CXCR4 restored functional responsiveness. We conclude that HepG2 is unresponsive to SDF stimulation because of a defect located after receptor binding but before the activation of the signalling cascade. A hypothetical blocking molecule could hinder receptor internalization or CXCR4 signalling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369512     DOI: 10.1016/s0898-6568(01)00156-5

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  13 in total

Review 1.  Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.

Authors:  Chun-Min Liang; Long Chen; Heng Hu; Hui-Ying Ma; Ling-Ling Gao; Jie Qin; Cui-Ping Zhong
Journal:  World J Hepatol       Date:  2015-06-08

2.  Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.

Authors:  C Lecointre; L Desrues; J E Joubert; N Perzo; P-O Guichet; V Le Joncour; C Brulé; M Chabbert; R Leduc; L Prézeau; A Laquerrière; F Proust; P Gandolfo; F Morin; H Castel
Journal:  Oncogene       Date:  2015-01-19       Impact factor: 9.867

3.  Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential.

Authors:  Tong-Chun Xue; Rong-Xin Chen; Dan Han; Jie Chen; Qiong Xue; Dong-Mei Gao; Rui-Xia Sun; Zhao-You Tang; Sheng-Long Ye
Journal:  Exp Ther Med       Date:  2011-09-29       Impact factor: 2.447

4.  CC chemokine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic cancer cells.

Authors:  Xiaoming Shen; Brian Mailey; Joshua D I Ellenhorn; Peiguo G Chu; Andrew M Lowy; Joseph Kim
Journal:  J Gastrointest Surg       Date:  2009-09-09       Impact factor: 3.452

5.  Cytoplasmic trapping of CXCR4 in hepatocellular carcinoma cell lines.

Authors:  Seong-Woo Kim; Ha-Yon Kim; Ik-Chan Song; Seon-Ah Jin; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Deog-Yeon Jo
Journal:  Cancer Res Treat       Date:  2008-06-30       Impact factor: 4.679

6.  CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells.

Authors:  Sarah M Eck; Anik L Côté; William D Winkelman; Constance E Brinckerhoff
Journal:  Mol Cancer Res       Date:  2009-07-07       Impact factor: 5.852

Review 7.  Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.

Authors:  Ismael Ghanem; Maria E Riveiro; Valerie Paradis; Sandrine Faivre; Paula M Vázquez de Parga; Eric Raymond
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

8.  Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.

Authors:  C C Schimanski; R Bahre; I Gockel; A Müller; K Frerichs; V Hörner; A Teufel; N Simiantonaki; S Biesterfeld; T Wehler; M Schuler; T Achenbach; T Junginger; P R Galle; M Moehler
Journal:  Br J Cancer       Date:  2006-07-04       Impact factor: 7.640

9.  CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.

Authors:  Maria Neve Polimeno; Caterina Ierano; Crescenzo D'Alterio; Nunzia Simona Losito; Maria Napolitano; Luigi Portella; Giosuè Scognamiglio; Fabiana Tatangelo; Anna Maria Trotta; Steven Curley; Susan Costantini; Raffaele Liuzzi; Francesco Izzo; Stefania Scala
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

10.  Fucoidan inhibits the growth of hepatocellular carcinoma independent of angiogenesis.

Authors:  Cong Zhu; Rui Cao; Shuang-Xia Zhang; Ya-Nan Man; Xiong-Zhi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.